184 related articles for article (PubMed ID: 30203153)
1. [Value of combining biologics with methotrexate for treatment of psoriatic arthritis-questions remain].
Dauth S; Köhm M; Rossmanith T; Herrmann E; Lehn A; Burkhardt H; Behrens F
Z Rheumatol; 2018 Nov; 77(9):808-814. PubMed ID: 30203153
[TBL] [Abstract][Full Text] [Related]
2. Tumour necrosis factor inhibitor monotherapy vs combination with MTX in the treatment of PsA: a systematic review of the literature.
Behrens F; Cañete JD; Olivieri I; van Kuijk AW; McHugh N; Combe B
Rheumatology (Oxford); 2015 May; 54(5):915-26. PubMed ID: 25349441
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the efficacy of biologics with and without methotrexate in the treatment of psoriatic arthritis: a network meta-analysis.
Mease PJ; Reddy S; Ross S; Lisse JR; Reis P; Griffing K; Sapin C; Vadhariya A; Furst DE
RMD Open; 2024 Jan; 10(1):. PubMed ID: 38296801
[TBL] [Abstract][Full Text] [Related]
4. Changes in Treatment Patterns in Patients with Psoriatic Arthritis Initiating Biologic and Nonbiologic Therapy in a Clinical Registry.
Mease PJ; Lesperance T; Liu M; Collier DH; Mason M; Deveikis S; Accortt NA
J Rheumatol; 2017 Feb; 44(2):184-192. PubMed ID: 28089969
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of ixekizumab in patients with active psoriatic arthritis with and without concomitant conventional disease-modifying antirheumatic drugs: SPIRIT-P1 and SPIRIT-P2 3-year results.
Coates LC; Mease P; Kronbergs A; Helt C; Sandoval D; Park SY; Combe B; Nash P; Deodhar A
Clin Rheumatol; 2022 Oct; 41(10):3035-3047. PubMed ID: 35674861
[TBL] [Abstract][Full Text] [Related]
6. The role of concomitant methotrexate in biologic therapy for rheumatoid arthritis.
Ruderman EM
Bull Hosp Jt Dis (2013); 2013; 71 Suppl 1():S29-32. PubMed ID: 24219038
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of methotrexate in management of peripheral psoriatic arthritis - a systematic review.
Ruhoff JT; Horn HC; Ellingsen T
Dan Med J; 2019 Oct; 66(10):. PubMed ID: 31571573
[TBL] [Abstract][Full Text] [Related]
8. Effect of tumour necrosis factor blockers on radiographic progression of psoriatic arthritis: a systematic review and meta-analysis of randomised controlled trials.
Goulabchand R; Mouterde G; Barnetche T; Lukas C; Morel J; Combe B
Ann Rheum Dis; 2014 Feb; 73(2):414-9. PubMed ID: 23355079
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness, tolerability, and safety of subcutaneous methotrexate in early rheumatoid arthritis: A retrospective analysis of real-world data from the St. Gallen cohort.
Müller RB; von Kempis J; Haile SR; Schiff MH
Semin Arthritis Rheum; 2015 Aug; 45(1):28-34. PubMed ID: 25895697
[TBL] [Abstract][Full Text] [Related]
10. Does Concomitant Methotrexate with Adalimumab Influence Treatment Outcomes in Patients with Psoriatic Arthritis? Data from a Large Observational Study.
Behrens F; Koehm M; Arndt U; Wittig BM; Greger G; Thaçi D; Scharbatke E; Tony HP; Burkhardt H
J Rheumatol; 2016 Mar; 43(3):632-9. PubMed ID: 26669916
[TBL] [Abstract][Full Text] [Related]
11. Triple Oral Therapy Versus Antitumor Necrosis Factor Plus Methotrexate (MTX) in Patients with Rheumatoid Arthritis and Inadequate Response to MTX: A Systematic Literature Review.
Mary J; De Bandt M; Lukas C; Morel J; Combe B
J Rheumatol; 2017 Jun; 44(6):773-779. PubMed ID: 28412710
[TBL] [Abstract][Full Text] [Related]
12. The role of antidrug antibodies in ustekinumab therapy and the impact of methotrexate.
Mojtahed Poor S; Henke M; Ulshöfer T; Köhm M; Behrens F; Burkhardt H; Schiffmann S
Rheumatology (Oxford); 2023 Dec; 62(12):3993-3999. PubMed ID: 37079726
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Etanercept Monotherapy and Combination Therapy with Methotrexate in Psoriatic Arthritis: Results from 2 Clinical Trials.
Combe B; Behrens F; McHugh N; Brock F; Kerkmann U; Kola B; Gallo G
J Rheumatol; 2016 Jun; 43(6):1063-7. PubMed ID: 27134249
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of methotrexate in comparison to biologics in rheumatoid arthritis.
Rau R
Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S58-64. PubMed ID: 21044435
[TBL] [Abstract][Full Text] [Related]
15. The GOLMePsA study protocol: an investigator-initiated, double-blind, parallel-group, randomised, controlled trial of GOLimumab and methotrexate versus methotrexate in early diagnosed psoriatic arthritis using clinical and whole body MRI outcomes.
De Marco G; Helliwell P; McGonagle D; Emery P; Coates LC; Hensor EMA; Marzo-Ortega H
BMC Musculoskelet Disord; 2017 Jul; 18(1):303. PubMed ID: 28720139
[TBL] [Abstract][Full Text] [Related]
16. Certolizumab pegol and secukinumab for treating active psoriatic arthritis following inadequate response to disease-modifying antirheumatic drugs: a systematic review and economic evaluation.
Corbett M; Chehadah F; Biswas M; Moe-Byrne T; Palmer S; Soares M; Walton M; Harden M; Ho P; Woolacott N; Bojke L
Health Technol Assess; 2017 Oct; 21(56):1-326. PubMed ID: 28976302
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate plus ustekinumab versus ustekinumab monotherapy in patients with active psoriatic arthritis (MUST): a randomised, multicentre, placebo-controlled, phase 3b, non-inferiority trial.
Koehm M; Rossmanith T; Foldenauer AC; Herrmann E; Brandt-Jürgens J; Burmester GR; Kellner H; Kiltz U; Kofler DM; Rech J; Mojtahed-Poor S; Jonetzko C; Burkhardt H; Behrens F;
Lancet Rheumatol; 2023 Jan; 5(1):e14-e23. PubMed ID: 38251504
[TBL] [Abstract][Full Text] [Related]
18. Similar short-term clinical response to high-dose versus low-dose methotrexate in monotherapy and combination therapy in patients with rheumatoid arthritis.
Bergstra SA; Allaart CF; van den Berg R; Chopra A; Govind N; Huizinga TWJ; Landewe RBM
Arthritis Res Ther; 2017 Nov; 19(1):258. PubMed ID: 29166919
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate and anti-tumor necrosis factor treatment improves endothelial function in patients with inflammatory arthritis.
Deyab G; Hokstad I; Whist JE; Smastuen MC; Agewall S; Lyberg T; Ronda N; Mikkelsen K; Hjeltnes G; Hollan I
Arthritis Res Ther; 2017 Oct; 19(1):232. PubMed ID: 29041979
[TBL] [Abstract][Full Text] [Related]
20. Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registry.
Weaver AL; Lautzenheiser RL; Schiff MH; Gibofsky A; Perruquet JL; Luetkemeyer J; Paulus HE; Xia HA; Leff JA;
Curr Med Res Opin; 2006 Jan; 22(1):185-98. PubMed ID: 16393444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
